Total Knee Replacement for Osteoarthritis
Trial Summary
What is the purpose of this trial?
The primary objective of this study is to obtain long-term implant survivorship (out to 10 years) and to assess clinical, patient-reported outcome measures, and radiographic data for the commercially available Physica system. For ancillary arm, from baseline to 5-year follow-up.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Physica Cruciate Retaining Knee System for total knee replacement?
Research suggests that the Physica KR implant, which retains the natural knee ligaments, may lead to better short-term functional outcomes and a more natural knee movement compared to conventional designs. This could result in improved range of motion and a more 'forgotten joint' feeling, meaning patients are less aware of their artificial joint.12345
Is the Physica KR knee replacement system safe for humans?
How does the Physica Knee System treatment for osteoarthritis differ from other treatments?
The Physica Knee System treatment for osteoarthritis is unique because it offers different designs like the Kinematic Retaining (KR) and Posterior Stabilized (PS) systems, which aim to improve knee function by either retaining or substituting the posterior cruciate ligament (PCL). This approach can lead to better functional outcomes and a more natural knee movement compared to conventional knee replacements.1451011
Research Team
Fabiana Pavan
Principal Investigator
Limacorporate S.p.a
Eligibility Criteria
This trial is for adults over 22 with knee issues like osteoarthritis, post-traumatic arthritis, rheumatoid arthritis, or deformities needing a total knee replacement. Candidates must be able to follow the study's rehab program and attend all visits. Exclusions include poor bone quality, active infections, certain past surgeries or conditions affecting bone health, pregnancy, and severe instability of the knee.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Subjects are implanted with one of the configurations of the Physica system: Physica KR, Physica CR, or Physica PS
Follow-up
Participants are monitored for implant survivorship, clinical performance, and patient-reported outcomes
Ancillary Follow-up
Ancillary subgroup follow-up for clinical and radiographic assessments
Treatment Details
Interventions
- Physica Cruciate Retaining Knee System (Prosthetic Device)
- Physica Cruciate Retaining Knee System with LMC Liner (Prosthetic Device)
- Physica Kinematic Retaining Knee System (Prosthetic Device)
- Physica Posterior Stabilized Knee System (Prosthetic Device)
Physica Cruciate Retaining Knee System is already approved in Canada for the following indications:
- Primary osteoarthritis
- Post-traumatic arthritis
- Rheumatoid arthritis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Limacorporate S.p.a
Lead Sponsor